Metabolic capabilities of CYP2F2 with various pulmonary toxicants and its relative abundance in mouse lung subcompartments

Citation
Ma. Shultz et al., Metabolic capabilities of CYP2F2 with various pulmonary toxicants and its relative abundance in mouse lung subcompartments, J PHARM EXP, 296(2), 2001, pp. 510-519
Citations number
38
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
ISSN journal
00223565 → ACNP
Volume
296
Issue
2
Year of publication
2001
Pages
510 - 519
Database
ISI
SICI code
0022-3565(200102)296:2<510:MCOCWV>2.0.ZU;2-J
Abstract
The tissue- and species-selective toxicity of a number of pulmonary toxican ts has been attributed to the presence and distribution of activating enzym es with high k(cat) in target airways of susceptible species. The mouse is especially sensitive to a variety of metabolically activated lung toxicants . Recombinant CYP2F2 (mouse) was recently shown to effectively metabolize t he species-selective pulmonary toxicant naphthalene. Here we show that the pulmonary toxicants 1-nitronaphthalene and 2-methylnaphthalene are metaboli zed readily with high kcat values (17.1 and 67.6 min(-1), respectively) to potentially cytotoxic intermediates at biologically relevant K-m values (21 .5 and 3.7 muM, respectively). Additionally, anthracene and benzo[a] pyrene are both metabolized by CYP2F2 (0.14 +/- 0.04 and 0.04 +/- 0.00 nmol/nmol/ min, respectively), albeit at much lower rates. The levels of total CYP in mouse airways are considerably higher than those in parenchyma and trachea, and this is consistent with much higher rates of naphthalene metabolism in microsomal preparations from airways compared with the other subcompartmen ts. The data suggest that CYP2F2 is a prominent cytochrome P450 in mouse lu ng that metabolizes a number of pulmonary toxicants. The presence of CYP2F2 may be important in the susceptibility of the mouse to metabolically activ ated pulmonary toxicants.